medigraphic.com
ISSN 1561-3011 (Electronic)

2020, Number 2

<< Back Next >>

Rev Cubana Invest Bioméd 2020; 39 (2)

Translational medicine in Peru, policy making and evidence-based improvement

Mejia CR, Montalvo R, Tresierra-Ayala M

Language: Spanish
References: 48
Page: 1-12
PDF size: 292.05 Kb.


ABSTRACT

Introduction: translational research is a branch of science of recent creation. Its main aim is the application of the knowledge generated by research so that it will not become grey literature printed on paper or for the use of a chosen few, but serve as many people and/or populations as possible.
Objective: determine the progress made in recent years in the application of translational medicine in Peru.
Methods: a convenience search was conducted in the databases Google Scholar and PubMed. Examples are offered of the way in which translational research may greatly contribute to improve specific realities and problems in Peru. This reinforces the need that political decisions be based on evidence-based medicine.
Results: translational medicine is faced with many difficulties in Peru, such as limited resources, scant time to implement training research, lack of updated pedagogical models, and teachers trained in old schools and with a limited capacity for continuing medical education. These hurdles should be overcome to ensure the progress of science and therefore of society as well.
Conclusions: progress of translational medicine in Peru has resulted in the training of more skilled health personnel, providing the means for the development of multiple public policies. In many cases those policies have been included in standards, regulations and even laws in the country.


REFERENCES

  1. Bernales M, Cabieses B, Obach A, Maturana A. Investigación traslacional en salud: un camino para la investigación pragmática e interdisciplinaria. Rev Médica Chile. 2015;143(1):128-9.

  2. Drucker DJ. Never waste a good crisis: confronting reproducibility in translational research. Cell Metab. 2016;24(3):348-60.

  3. Yin HL, Gabrilove J, Jackson R, Sweeney C, Fair AM, Toto R. Sustaining the clinical translational research workforce: training and empowering the next generation of investigators. Acad Med J Assoc Am Med Coll. 2015;90(7):861.

  4. Cohrs RJ, Martin T, Ghahramani P, Bidaut L, Higgins PJ, Shahzad A. Translational medicine definition by the European Society for Translational Medicine. Elsevier; 2015.

  5. Crippa JA, Guimarães FS, Campos AC, Zuardi AW. Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age. Front Immunol. 2018;9.

  6. Colusso L, Bennett CL, Hsieh G, Munson SA. Translational resources: Reducing the gap between academic research and HCI practice. En: Proceedings of the 2017 Conference on Designing Interactive Systems. ACM; 2017. p. 957-68.

  7. Woolf SH. The meaning of translational research and why it matters. Jama. 2008;299(2):211-3.

  8. Cabieses B, Espinoza MA. La investigación traslacional y su aporte para la toma de decisiones en políticas de salud. Rev Peru Med Exp Salud Pública. 2011;28:288–97.

  9. Mazzetti P, Inca-Martínez M, Tirado-Hurtado I, Milla-Neyra K, Silva-Paredes G, Vishnevetsky A, et al. Neurogenética en el Perú, ejemplo de investigación traslacional. SciELO Public Health; 2015.

  10. Aranzábal-Alegría G, Quiñones-Laveriano DM, Verastegui-Diaz A, Robles-Esquerre JM. Investigación traslacional para el desarrollo de la fitoterapia en Perú. Rev Gastroenterol Perú. 2016;36(1).

  11. LEGUA P. Malaria en el Perú. Rev Medica Hered. 1994;5(3).

  12. Durand S, Lachira-Alban A, Sánchez CC. Impacto de diferentes esquemas terapéuticos sobre la malaria en la costa y amazonia peruana, en el marco de una política de medicamentos antimaláricos, 1994-2017. Rev Peru Med Exp Salud Pública. 2018;35:497-504.

  13. Treatment (EANMAT) EAN for MA. Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience. Trop Med Int Health. 2001;6(11):891-8.

  14. Pan American Health Organization. Evaluation of the Therapeutic Efficacy of Drugs for the Treatment of Uncomplicated Plasmodium falciparum Malaria in the Americas. Washington DC; 1998. (OPS/HCP/HCT/113/98).

  15. RUEBUSH II TK, Marquino W, Zegarra J, Neyra D, Villaroel R, Avila JC, et al. Practical aspects of in vivo antimalarial drug efficacy testing in the Americas. Am J Trop Med Hyg. 2003;68(4):391-7.

  16. Curioso WH, Hansen JR, Centurion-Lara A, Garcia PJ, Wolf FM, Fuller S, et al. Evaluation of a joint Bioinformatics and Medical Informatics international course in Peru. BMC Med Educ. 2008;8(1):1.

  17. Tomatis C, Taramona C, Rizo-Patrón E, Hernández F, Rodríguez P, Piscoya A, et al. Evidence-based medicine training in a resource-poor country, the importance of leveraging personal and institutional relationships. J Eval Clin Pract. 2011;17(4):644-50.

  18. Pappaioanou M, Malison M, Wilkins K, Otto B, Goodman RA, Churchill RE, et al. Strengthening capacity in developing countries for evidence-based public health:: the data for decision-making project. Soc Sci Med. 2003;57(10):1925-37.

  19. Congreso de la Republica. Ley de Seguridad y Salud en el Trabajo. Diario el Peruano, 29783 ago 20, 2011.

  20. Presidencia del Consejo de Ministros. Decreto Supremo N° 015-2005-SA: Reglamento sobre Valores Límite Permisibles para Agentes Quimicos en el Ambiente de Trabajo. DS, Ley 26842 2005.

  21. Presidencia del Consejo de Ministros. Normas Técnicas del Seguro Complementario de Trabajo de Riesgo. DS, Ley 26790 1998 p. 37.

  22. Presidencia del Consejo de Ministros. Reglamento de la Ley N° 29783, Ley de Seguridad y Salud en el Trabajo. DS, Ley 29783 2012.

  23. Presidencia del Consejo de Ministros. Reglamento de Prevención y Control del Cáncer Profesional. DS, Ley 21601 1993 p. 7.

  24. OIT. Guía para el uso de la Clasificación Internacional de la OIT de Radiografias de Neumoconiosis. 2011.

  25. MINSA. NTS N°068 - MINSA/DGSP - V.1 - Norma Técnica de Salud que Establece el Listado de Enfermedades Profesionales. 2008.

  26. Mejia CR, Cárdenas MM, Gomero-Cuadra R. Notificación de accidentes y enfermedades laborales al Ministerio de Trabajo. Perú 2010-2014. Rev Peru Med Exp Salud Pública. 2015;32:526-31.

  27. Hernández-Vásquez A, Díaz-Seijas D, Vilcarromero S, Santero M. Distribución espacial de los accidentes y enfermedades relacionados con el trabajo en el Perú, 2012-2014. Rev Peru Med Exp Salud Pública. 2016;33:106-12.

  28. Cairney P. The politics of evidence-based policy making. Springer; 2016.

  29. Evans SC, Roberts MC, Keeley JW, Blossom JB, Amaro CM, Garcia AM, et al. Vignette methodologies for studying clinicians‟ decision-making: validity, utility, and application in ICD-11 field studies. Int J Clin Health Psychol. 2015;15(2):160-70.

  30. Ahmadi-Abhari S, Soltani A, Hosseinpanah F. Knowledge and attitudes of trainee physicians regarding evidence-based medicine: a questionnaire survey in Tehran, Iran. J Eval Clin Pract. 2008;14(5):775-9.

  31. Tur RG, Rivera JM, Acosta ÁD. Estrategia educativa para la formación científico-profesional del estudiante de psicología. Resultados de su aplicación parcial. Opuntia Brava. 2017;9(1):291-304.

  32. Adeloye D. Key challenges of evidence-based medicine in developing countries. Res J Health Sci. 2015;3(3):139-48.

  33. Gilbert BJ, Patel V, Farmer PE, Lu C. Assessing development assistance for mental health in developing countries: 2007–2013. PLoS Med. 2015;12(6):e1001834.

  34. Puustjärvi J, Puustjärvi L. Practicing evidence-based medicine in developing countries. En: 2015 IST-Africa Conference. IEEE; 2015. p. 1-9.

  35. Brownson RC, Colditz GA, Proctor EK. Dissemination and implementation research in health: translating science to practice. Oxford University Press; 2018.

  36. Kelly MP, Heath I, Howick J, Greenhalgh T. The importance of values in evidence-based medicine. BMC Med Ethics. 2015;16(1):69.

  37. Lang E, Bayat Z. Evidence-based medicine. En: Doing Research in Emergency and Acute Care. 2015.

  38. Fung FY, Linn YC. Developing traditional Chinese medicine in the era of evidence-based medicine: current evidences and challenges. Evid Based Complement Alternat Med. 2015;2015.

  39. McMichael C, Waters E, Volmink J. Evidence-based public health: what does it offer developing countries? J Public Health. 2005;27(2):215-21.

  40. Kelly M, Morgan A, Ellis S, Younger T, Huntley J, Swann C. Evidence based public health: a review of the experience of the National Institute of Health and Clinical Excellence (NICE) of developing public health guidance in England. Soc Sci Med. 2010;71(6):1056-62.

  41. Curtis K, Fry M, Shaban RZ, Considine J. Translating research findings to clinical nursing practice. J Clin Nurs. 2017;26(5-6):862-72.

  42. Harvey G, Kitson A. Implementing evidence-based practice in healthcare: a facilitation guide. Routledge; 2015.

  43. Gagliardi AR, Berta W, Kothari A, Boyko J, Urquhart R. Integrated knowledge translation (IKT) in health care: a scoping review. Implement Sci. 2015;11(1):38.

  44. Chinnock P, Siegfried N, Clarke M. Is evidence-based medicine relevant to the developing world? Evid Based Complement Alternat Med. 2005;2(3):321-4.

  45. Høj L. Just do like us… about the dispersion of „evidence‟from high-income countries to settings with limited resources. Acta Obstet Gynecol Scand. 2005;84(10):927-8.

  46. Kieny MP, Bekedam H, Dovlo D, Fitzgerald J, Habicht J, Harrison G, et al. Strengthening health systems for universal health coverage and sustainable development. Bull World Health Organ. 2017;95(7):537.

  47. Ogundahunsi OA, Vahedi M, Kamau EM, Aslanyan G, Terry RF, Zicker F, et al. Strengthening research capacity-TDR‟s evolving experience in low-and middle-income countries. PLoS Negl Trop Dis. 2015;9(1):e3380.

  48. Santesso N, Tugwell P. Knowledge translation in developing countries. J Contin Educ Health Prof. 2006;26(1):87-96.




2020     |     www.medigraphic.com